Nestle has a newly-acquired company, and it is the protein shake maker, Orgain. The latter produces plant-based bars, shakes, and protein powders, and the Swiss multinational food and drink processing company headquartered in Vevey, Vaud, Switzerland, bought a majority stake for an undisclosed amount.
Andrew Abraham, Orgain's founder, and Butterfly Equity will remain shareholders of the company once the deal is completed. According to Food Dive, the agreement between Nestle and Orgain includes the option for the former to buy the rest of the shares in the company in 2024. Abraham will also retain his position as the chief executive officer of Orgain.
It was said that the stake acquisition will push and step up Nestlé's efforts to grow its health and wellness business unit. To attain its goal, the company will also be removing some of its divisions that are growing slowly compared to the others.
In fact, Nestlé already offloaded its confections and ice cream businesses and last year, it has also disposed of the majority of its North American bottled waters business for $4.3 billion as it was already struggling to stay afloat.
With its new deal with Orgain, Nestle will also be able to focus more on its other international premium brands that have big potential to grow further such as Perrier. Orgain will also give the firm fresh products to offer especially with the growing demand for plant-based items around the world. Furthermore, Orgain will give Nestle a deeper presence in trendy categories that are becoming really popular with consumers.
"Nutritional protein plays a key role in supporting our health and wellness, whether we enjoy an active lifestyle or are facing health challenges," Nestlé Health Science chief executive officer, Greg Behar, said in a press release. "Orgain's emphasis on clean, all natural, plant-based, organic ingredients has made it a leader in the U.S., and we look forward to combining our companies' expertise to bring Orgain to more people around the world."
Dr. Abraham, CEO and Founder of Orgain, also said, "We've worked hard to develop innovative products that make a real difference in consumers' lives, and now through Nestlé Health Science's capabilities, resources and dedication to nutrition, we will be able to reach more people around the world."
Meanwhile, the acquisition deal is still subject to customary regulatory approvals.


US Dollar Rises as Fed Rate Outlook Stays Hawkish, Euro Slips and Yen Near 40-Year Low
Michael Burry Shorts Tesla at $416 as AI and Semiconductor Bearish Bets Expand
Morgan Stanley Names BAE Systems Top European Defence Stock Despite Lower Price Target
Kawasaki Heavy Shares Slide on Report of ¥200 Billion Capital Raise Plan
Trump Administration to Launch Voluntary AI Standards for Frontier Models
Trump Administration Declines USMCA Renewal, Opens Talks on New Trade Changes
Nvidia Stock Rises as SemiAnalysis Sees AI Data Center Revenue Beating Wall Street Forecasts
OpenAI Proposes 5% U.S. Government Stake Amid AI Policy Talks
Oil Prices Slip as Iran Talks and Strong Supply Outlook Ease Market Concerns
Gold Price Hits Annual Low as Fed Rate Hike Bets and Sticky Inflation Weigh on Bullion
Wall Street Futures Rise Ahead of JOLTS Data, Nike Earnings, and U.S.-Iran Talks
Microsoft Reportedly Plans New Job Cuts Across Sales, Consulting, and Xbox
Trump Reports $1.4 Billion in Crypto Income as Digital Assets Become Top Wealth Source
India Manufacturing PMI Slows in June as Demand Weakens Despite Lower Cost Pressures
South Korea Warns Won Is Undervalued, Boosts FX Coordination With Japan
SK Holdings, KKR Launch $1.3B Renewable Energy Venture in South Korea
South Korean Stocks Tumble as AI Chip Selloff Hits Asian Markets 



